BIOVENTUS LLC
DURHAM, NC

BIOVENTUS LLC is a leading company in the biotechnology sector, dedicated to partnering with healthcare communities worldwide to support individuals in regaining active lifestyles. Since its establishment in 2012 and based in Durham, North Carolina, Bioventus has become a trusted name through its commitment to clinically proven orthobiologic solutions designed for bone healing, bone grafts, and osteoarthritis treatment. The company emphasizes safety, innovation, and effectiveness across two primary product segments: Bioventus Active Healing Therapies and Bioventus Surgical. Bioventus develops and markets products that support accelerated recovery from bone fractures, alleviates chronic pain associated with osteoarthritis, and may reduce the need for invasive medical procedures. With a strong focus on evidence-based medicine, high-quality standards, and ethical practices, the company is recognized as a vital extension of healthcare providers' services. Employing over 700 professionals worldwide across key locations in North America, Europe (including its international headquarters in Hoofddorp, Netherlands), Australia, Canada, and a research and development facility in Boston, Bioventus generates approximately $300 million annually. Its reach extends to various global stakeholders such as patients, payers, and healthcare providers in over 30 countries. Complementing its operational achievements is Bioventus's legal identity marked by its registered trademarks 'Bioventus', 'the Bioventus logo', and 'EXOGEN'. Governed under the status of Florida.Models.Dos.FloridaCompanyStatus, it ensures compliance with its incorporation details including but not limited to a mailing address at 4721 Emperor Blvd, Ste 100 in Durham, NC, with an FEI number 45-3935628. As indicated in recent reports, Bioventus's last significant activity was a reinstatement dated October 14, 2021, and it filed its most current annual report on April 12, 2024, for the year 2024.